---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-164481"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T04:14:04.436586+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Ikena Oncology shareholders elect three Class II directors, ratify E&Y as auditor

## Summary
- David Bonita (16.5M for, 7.6M against, 2.3M broker non-votes) elected to three-year term.
- Jean-François Formela (20.8M for, 3.3M against) and Richard Wooster (20.8M for, 3.3M against) also elected.
- Ernst & Young LLP ratified as independent auditor for FY2023 with 26.4M for, 9k against, 1.3k abstain.

## SEC filing metadata
- accession: 0001193125-23-164481
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312523164481/0001193125-23-164481-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312523164481/d483896d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-164481
- JSON: https://secwatch.observer/filing/0001193125-23-164481.json
- Plain text: https://secwatch.observer/filing/0001193125-23-164481.txt

## Key facts
- Shareholder Votes
  ImageneBio, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-09
  source text: The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 26,385,702 9,069 1,307 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312523164481/0001193125-23-164481-index.htm
- Shareholder Votes
  ImageneBio, Inc. shareholders approved Election of Class II Directors: David Bonita, M.D., Jean-François Formela, M.D., and Richard Wooster, Ph.D. at the 2023-06-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-09
  source text: The votes cast at the Annual Meeting were as follows: For Withheld Broker Non-Votes David Bonita, M.D. 16,468,374 7,623,868 2,303,836 Jean-François Formela, M.D. 20,781,723 3,310,519 2,303,836 Richard Wooster, Ph.D. 20,784,244 3,307,998 2,303,836
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312523164481/0001193125-23-164481-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.